• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA:癌症中的潜在生物标志物。

MicroRNAs: Potential biomarkers in cancer.

作者信息

George G P, Mittal Rama Devi

机构信息

Department of Urology and Renal Transplantation, Sanjay Gandhi and Post Graduate Institute of Medical Sciences, Lucknow, U.P. 226014 India.

出版信息

Indian J Clin Biochem. 2010 Jan;25(1):4-14. doi: 10.1007/s12291-010-0008-z. Epub 2010 Feb 10.

DOI:10.1007/s12291-010-0008-z
PMID:23105877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3453005/
Abstract

microRNAs (miRNAs) are evolutionarily conserved small noncoding RNAs, also known as micromanagers of gene expression. Polymorphisms in the miRNA pathway (miR-polymorphisms) are emerging as powerful tools to study the biology of a disease and have the potential to be used in disease prognosis and diagnosis. Advancements in the miRNA field also indicate a clear involvement of deregulated miRNA gene signatures in cancers, and several polymorphisms in pre-miRNA, miRNA binding sites or targets have been found to be associated with various cancers. The miRNA polymorphisms have also been reported to influence tumor aggressiveness as well as survival of cancer patients. miRNAs have a revolutionary impact on cancer research over recent years. They emerge as important players in tumorigenesis, leading to a paradigm shift in oncology. The extensive and comprehensive use of miRNA microarrays has enabled the identification of a number of miRNAs as potential biomarkers for cancer. Many miRNAs have been identified to act as oncogenes, tumor suppressors, or even modulators of cancer stem cells and metastasis. Some studies not only reported the identified miRNA biomarkers, but also deciphered their target genes and the underlying mechanisms. The rapid discovery of many miRNA targets and their relevant pathways has contributed to the development of miRNA-based therapeutics.

摘要

微小RNA(miRNA)是进化上保守的小非编码RNA,也被称为基因表达的微观管理者。miRNA途径中的多态性(miR-多态性)正成为研究疾病生物学的有力工具,并有可能用于疾病的预后和诊断。miRNA领域的进展还表明,失调的miRNA基因特征在癌症中明显起作用,并且已发现前体miRNA、miRNA结合位点或靶标的几种多态性与各种癌症相关。据报道,miRNA多态性也会影响肿瘤的侵袭性以及癌症患者的生存率。近年来,miRNA对癌症研究产生了革命性的影响。它们成为肿瘤发生中的重要参与者,导致肿瘤学领域的范式转变。miRNA微阵列的广泛和全面使用使得能够鉴定出许多miRNA作为癌症的潜在生物标志物。许多miRNA已被鉴定为癌基因、肿瘤抑制因子,甚至是癌症干细胞和转移的调节因子。一些研究不仅报道了已鉴定的miRNA生物标志物,还破译了它们的靶基因和潜在机制。许多miRNA靶标及其相关途径的快速发现促进了基于miRNA的治疗方法的发展。

相似文献

1
MicroRNAs: Potential biomarkers in cancer.微小RNA:癌症中的潜在生物标志物。
Indian J Clin Biochem. 2010 Jan;25(1):4-14. doi: 10.1007/s12291-010-0008-z. Epub 2010 Feb 10.
2
MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.微小 RNA:癌症诊断、预后的潜在生物标志物和治疗靶点。
Int J Biochem Cell Biol. 2010 Aug;42(8):1273-81. doi: 10.1016/j.biocel.2009.12.014. Epub 2009 Dec 22.
3
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.微小RNA多态性:药物基因组学、分子流行病学及个体化医学的未来
Pharmacogenomics. 2009 Mar;10(3):399-416. doi: 10.2217/14622416.10.3.399.
4
Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.人类 microRNA 癌基因和肿瘤抑制基因表现出显著不同的生物学模式:从功能到靶标。
PLoS One. 2010 Sep 30;5(9):e13067. doi: 10.1371/journal.pone.0013067.
5
Small players with big roles: microRNAs as targets to inhibit breast cancer progression.小角色,大作用:微小 RNA 作为抑制乳腺癌进展的靶点。
Curr Drug Targets. 2010 Sep;11(9):1059-73. doi: 10.2174/138945010792006762.
6
Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.白血病中 miRNA 的失调:利用 miRNA 表达谱作为生物标志物。
Int J Mol Sci. 2021 Jul 2;22(13):7156. doi: 10.3390/ijms22137156.
7
The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.线粒体miRNA在人类疾病病理生理学中的新兴作用
Adv Exp Med Biol. 2015;888:123-54. doi: 10.1007/978-3-319-22671-2_8.
8
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
9
microRNAs as oncogenes and tumor suppressors.作为癌基因和肿瘤抑制因子的微小RNA
Dev Biol. 2007 Feb 1;302(1):1-12. doi: 10.1016/j.ydbio.2006.08.028. Epub 2006 Aug 16.
10
miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.miRNA 谱分析确定了与骨肉瘤发生和转移时间相关的失调 miRNA,该分析基于两个大型队列。
Mol Oncol. 2018 Jan;12(1):114-131. doi: 10.1002/1878-0261.12154. Epub 2017 Dec 1.

引用本文的文献

1
Exosome-based approaches in cancer along with unlocking new insights into regeneration of cancer-prone tissues.基于外泌体的癌症治疗方法,以及对癌症易患组织再生的新见解。
Regen Ther. 2025 Mar 26;29:202-216. doi: 10.1016/j.reth.2025.03.005. eCollection 2025 Jun.
2
Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.穿心莲内酯通过抑制 ER-α 受体和 PI3K/AKT/mTOR 信号通路的失活来抑制细胞增殖并诱导细胞凋亡,从而发挥对乳腺癌细胞(MCF-7 和 MDA-MB-231 细胞)的抗癌活性。
Molecules. 2022 May 31;27(11):3544. doi: 10.3390/molecules27113544.
3
Serum microRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma: a meta-analysis.血清 microRNAs 作为甲状腺乳头状癌诊断的生物标志物:一项荟萃分析。
Bosn J Basic Med Sci. 2022 Oct 23;22(6):862-871. doi: 10.17305/bjbms.2022.7343.
4
Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?循环 miRNA 作为 2 型糖尿病的潜在生物标志物:我们是否应该专注于寻找性别差异?
J Appl Genet. 2022 May;63(2):293-303. doi: 10.1007/s13353-021-00678-5. Epub 2022 Jan 5.
5
MicroRNAs as a Suitable Biomarker to Detect the Effects of Long-Term Exposures to Nanomaterials. Studies on TiONP and MWCNT.微小RNA作为检测长期暴露于纳米材料影响的合适生物标志物。关于二氧化钛纳米颗粒和多壁碳纳米管的研究。
Nanomaterials (Basel). 2021 Dec 20;11(12):3458. doi: 10.3390/nano11123458.
6
Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer.循环微小RNA-141在上皮性卵巢癌中的表达
Malays J Med Sci. 2020 Dec;27(6):27-38. doi: 10.21315/mjms2020.27.6.4. Epub 2020 Dec 1.
7
Serum expression and significance of MicroRNA-30d-5p in esophageal squamous cell carcinoma.微小RNA-30d-5p在食管鳞状细胞癌中的血清表达及意义
Int J Clin Exp Pathol. 2017 Aug 1;10(8):8677-8685. eCollection 2017.
8
Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells.肝细胞癌、癌症干细胞和间充质干细胞中失调的微小RNA指纹图谱和甲基化模式
Front Cell Dev Biol. 2019 Oct 17;7:229. doi: 10.3389/fcell.2019.00229. eCollection 2019.
9
Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells.hsa-let-7c-5p上调对人急性红白血病细胞的抗增殖作用。
Cytotechnology. 2018 Dec;70(6):1509-1518. doi: 10.1007/s10616-018-0241-5. Epub 2018 Aug 2.
10
Apoptosis induction in acute promyelocytic leukemia cells through upregulation of by miR-182 blockage.通过miR-182阻断上调来诱导急性早幼粒细胞白血病细胞凋亡。
Mol Biol Res Commun. 2018 Mar;7(1):25-33. doi: 10.22099/mbrc.2018.27625.1297.

本文引用的文献

1
MicroRNA Gene Networks in Oncogenesis.微小 RNA 基因网络在肿瘤发生中的作用。
Curr Genomics. 2009 Mar;10(1):35-41. doi: 10.2174/138920209787581299.
2
MicroRNAs: novel regulators in the hallmarks of human cancer.微小RNA:人类癌症特征中的新型调节因子。
Cancer Lett. 2009 Nov 28;285(2):116-26. doi: 10.1016/j.canlet.2009.04.031. Epub 2009 May 22.
3
Many roads to maturity: microRNA biogenesis pathways and their regulation.通向成熟的多条途径:微小RNA生物合成途径及其调控
Nat Cell Biol. 2009 Mar;11(3):228-34. doi: 10.1038/ncb0309-228.
4
Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.微小RNA相关基因的遗传变异是食管癌风险的新型易感位点。
Cancer Prev Res (Phila). 2008 Nov;1(6):460-9. doi: 10.1158/1940-6207.CAPR-08-0135.
5
The roles of microRNA in cancer and apoptosis.微小RNA在癌症和细胞凋亡中的作用。
Biol Rev Camb Philos Soc. 2009 Feb;84(1):55-71. doi: 10.1111/j.1469-185X.2008.00061.x. Epub 2008 Nov 22.
6
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.具有高危分子特征的细胞遗传学正常的急性髓系白血病中CEBPA突变的预后意义以及与之相关的基因和微小RNA表达特征:癌症与白血病B组研究
J Clin Oncol. 2008 Nov 1;26(31):5078-87. doi: 10.1200/JCO.2008.17.5554. Epub 2008 Sep 22.
7
Functional genetic variation of human miRNAs and phenotypic consequences.人类微小RNA的功能遗传变异及其表型后果。
Mamm Genome. 2008 Aug;19(7-8):503-9. doi: 10.1007/s00335-008-9137-6. Epub 2008 Sep 12.
8
MicroRNA target site polymorphisms and human disease.微小RNA靶位点多态性与人类疾病
Trends Genet. 2008 Oct;24(10):489-97. doi: 10.1016/j.tig.2008.07.004. Epub 2008 Sep 6.
9
An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway.一张针对十五种常见人类疾病的单核苷酸多态性(SNP)引导的微小RNA图谱确定了一个针对核输入途径主要成分的共识疾病表型编码。
Cell Cycle. 2008 Aug 15;7(16):2570-83. doi: 10.4161/cc.7.16.6524. Epub 2008 Aug 30.
10
Radiation modulation of microRNA in prostate cancer cell lines.前列腺癌细胞系中微小RNA的辐射调节
Prostate. 2008 Nov 1;68(15):1599-606. doi: 10.1002/pros.20827.